Clinical Trial Update: Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK). [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a PEG-400 based artificial tear with Systane for dry eye signs and symptoms after myopic LASIK; the study status is completed. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• PEG-400 based artificial tear (polyethylene glycol-based artificial tear)
• Systane

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED